HIGHLIGHTS
- who: Alejandro Llanos-Cuentas from the Instituto de Medicina Tropical Alexander Von Humboldt, Universidad Porres, Lima, Peru have published the research work: Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial, in the Journal: (JOURNAL)
SUMMARY
As the novel coronavirus SARS-CoV-2 spread globally, many opted to repurpose readily available medications to combat the damaging effects of COVID-19. As a result of the inmense death toll, and given that vaccine candidates were still under research, the authors sought . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.